Pentosanpolysulphate for interstitial cystitis

International Urogynecology Journal

Volumn 8, Issue 5, 1997, Pages 293-295

  Barrington, J W ^a   Stephenson, T P ^b  

^a TORBAY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Defective GAG layer; Interstitial cystitis; Pentosanpolysulphate

Indexed keywords

GLYCOSAMINOGLYCAN; PENTOSAN POLYSULFATE; PROTEOGLYCAN; TOXIC SUBSTANCE;

CELL SURFACE; CHEMICAL STRUCTURE; HUMAN; INFLAMMATION; INTERSTITIAL CYSTITIS; LAMINA PROPRIA; PRIORITY JOURNAL; SHORT SURVEY; URINE; URINE VOLUME; UROTHELIUM;

EID: 0031416583     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02765487     Document Type: Short Survey

References (35)

1. Nietze M. Lehrbuch de kystosskopie: Ihre lechnik und klinische bedeutung. Berlin: JE Bergman, 1907;410
2. Hunner GL. A rare type of bladder ulcer in women: report of cases. Boston Med Surg J 1915;172:660-664
3. Walsh A. Interstitial cystitis. In: Hanson JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC, eds. Campbell's urology, 4th edn. Philadelphia: WB Saunders, 1978;693-707
4. Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol 1975;64:75
5. Hanno P, Wein A, Pauly M, Held P. Epidemiology and serial cost of interstital cystitis. J Urol 1988;139-276
6. De Juana CP, Everett JC. Interstitial cystitis, experience and review of recent literature. Urology 1977;10:325-329
7. Koziol JC, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol 1993;143:465-469
8. Messing EM, Stamey TA. Interstitial cystitis, early diagnosis, pathology and treatment. Urology 1978;12:381-392
9. Holm-Bentzen M, Jacobsen F, Nerstrom B et al. A prospective double-blind clinically controlled multicenter trial of Elmiron (sulphopentosan sodium) in the treatment of interstitial cystitis and related painful bladder diseases. J Urol 1987;137:503-507
10. Holm-Bentzen M, Lose G. Pathology and pathogenesis of interstitial cystitis. Urology 1987;29:8-13
11. Messing EM. Interstitial cystitis and related syndromes. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, eds. Campbell's urology, 5th edn. Philadelphia: WB Saunders, 1992;982-1006
12. Dixon JS, Gosling JA. The anatomy of the bladder, urethra and pelvic floor. In: Mundy AR, Stephenson TP, Wein AJ, eds. Urodynamics. Principles, practice and application, 2nd edn. Edinburgh: Churchill Livingstone, 1994;3-14
13. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 1990;143:139-142
14. Gregor HP. Anticoagulant activity of sulfonate polymers and copolymers. In: Gregor HP, ed. Polymer sciences and technology. New York: Plenum Press, 1975;5-56
15. Gregor HP. Fixed-charge ultrafiltration membranes. In: Selegny E. Charged gels and membranes. Amsterdam: D Reidel, 1976;235
16. Gryte CC, Gregor HP. Poly-(styrene sulfonic acid)-(vinyl-lidene fluoride) interpolymer ion-exchange membranes. Polym Sci 1976;14:1839
17. Parsons CL, Greenspan C, Moore SW, Mullholland SG. Role of surface mucin in primary antibacterial defence of bladder. Urology 1977;9:3:48-55
18. Dixon JS, Holm-Bentzen M, Gilpin CJ et al. Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. J Urol 1986;135:621-625
19. Eldrup J, Thorup J, Nielson SL, Hald T, Hainau B. Permeability and ultrastructure of human bladder epithelium. Br J Urol 1983;55:488-492
20. Lepinard V, Saint-Andre JP, Rogan LM. La Cystite intestitielle. J d'Urol 1984;90:455-465
21. Fowler JE, Lau JLT, Ghosh L, Mounze A, Lynes WL. Interstitial cystitis is associated with intraurothelial Tamm-Horsfall protein. J Urol 1988;139:276
22. Holm-Bentzen M, Ammitzball T, Hald T. Glycosaminoglycans on the surface of the human urothelium: a preliminary report. Neurourol Urodyn 1986;5:519-523
23. Sant GR, Ucci AA, Alroy J. Bladder glycosaminoglycans (GAGs) in interstitial cystitis. J Urol 1986;135:175
24. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev 1978;58:225-316
25. Jacques LB. Heparins - anionic polyelectrolyte drugs. Pharmacol Rev 1980;31:99-104
26. Weaver RG. Dougherty TF, Natolic CA. Recent concepts of interstitial cystitis. J Urol 1963;89:377-380
27. Lose G, Jespersen J, Frandsen B, Hojensgaard JC, Astrup T. Subcutaneous heparin in the treatment of interstitial cystitis. Scand J Urol Nephrol 1985;19:27-29
28. Barrington JW, Fraylin L, Fish R, Shelley M, Stephenson TP. Elevated levels of basic fibroblast growth factor in the urine of clam enterocystoplasty patients. J Urol 1996;155:468-470
29. Barrington JW, Fulford S, Fraylin L, Fish R, Shelley M, Stephenson TP. The use of pentosan polysulphate sodium to reduce urinary basic fibroblast growth factor in clam enterocystoplasty patients. Br J Urol 1996;78:54-56
30. Toozs-Hobson P, Gleeson C, Cardoza L. Interstitial cystitis - still an enigma after 80 years. Br J Obstet Gynaecol 1996;193:621-624
31. Parsons CL, Mulholland SG. Successful therapy of interstitial cystitis with pentosanpolysulfate sodium. J Urol 1987;138:513-516
32. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosanpolysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology 1990;135:552-558
33. Fritjofsson QA, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J Urol 1987;138:508-512
34. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993;150:845-848
35. Perez-Marrero R, Emerson LE, Maharajh DO. Prolongation of response to DMSO by heparin maintenance. Urology 1993;41:64.